A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “A case report of donor cell–derived ...

The mother of a seven-year-old with a life-threatening blood disorder says despite treatments being the same as cancer, they ...

One hundred people have signed up to the stem cell register to see if they are a match for a man who has blood cancer.

For four decades, Ohio State blood and bone marrow transplant innovation has improved cancer care with an increasing emphasis ...

Childhood blood cancer devastates families across South Africa, with survival rates alarmingly low. Discover the challenges ...

Unrelated cord blood transplant demonstrated efficacy in patients with blood cancer after microcystic adnexal carcinoma.

How Healthy Stem Cells Turn Into Oral Cancer Feb. 4 ... 2024 — Stem cell transplantation is used to treat several types of blood cancers, but carries the risk of a life-threatening side effect ...

More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...

Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...

Penn State Cancer Institute in Hershey has again earned international reaccreditation for stem cell transplantation.

Hematopoietic stem cell transplantation (HSCT) is a vital treatment for both malignant and non-malignant disorders in pediatric patients.